N-Terminal Pro-Brain Natriuretic Peptide and Risk of Cardiovascular Events in a Japanese Community: The Hisayama Study

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.111.223669
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

N-Terminal Pro–brain Natriuretic Peptide and Abnormal Brain Aging

Neurology
Neurology
2015English

The Prognostic Value of the Plasma N-Terminal Pro-Brain Natriuretic Peptide Level on All-Cause Death and Major Cardiovascular Events in a Community-Based Population

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2016English

NH2-Terminal Pro-Brain Natriuretic Peptide and Risk of Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

N-Terminal Pro-Brain Natriuretic Peptide Levels and Aortic Diameters

American Heart Journal
Cardiovascular MedicineCardiology
2012English

Possible Mechanisms Underlying Elevated Serum N-Terminal Pro-Brain Natriuretic Peptide in Healthy Japanese Subjects

Circulation Reports
2019English

Reliability of N-Terminal Pro-Brain Natriuretic Peptide Assay in Diagnosis of Heart Failure: Cohort Study in Representative and High Risk Community Populations

BMJ
2002English

Bradyarrhythmia Can Increase the Plasma Level of N-Terminal Pro-Brain Natriuretic Peptide

International Journal of Arrhythmia
2016English

NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2019English

Perioperative Application of N-Terminal Pro-Brain Natriuretic Peptide in Patients Undergoing Cardiac Surgery

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy